2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Poster Session

[P33] Poster Session 33　Breast Cancer（Basic science, Biomarker）

[P33-2] PARP inhibitor has synergic effect with mTOR inhibitor or E2 for treatment-resistant model cells of ER（+）breast cancer

○Minori Tsukahara (Department of Molecular and Functional Dynamics, Graduate School of Medicine, Tohoku University)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password